Mechanistic Model for Respiratory Depression Simulation

The 2024 update to our translational PK-PD model predicts overdose and recovery under naloxone, an opioid antagonist. This improved version explores the integration of system mechanisms into deep learning frameworks.

Model Structure

The model simulates clinical situations with constant, elevated alveolar CO2 partial pressure. It comprises three components:

Receptor Binding

“`
$\frac{d{R}_{L}}{dt}={K}_{on}{L}^{n}R-{K}_{off}{R}_{L}$
“`

* L: Free ligands (opioids/naloxone)
* R: Free opioid receptors
* RL: Ligand-occupied receptors
* Kon, Koff, n: Association rate, dissociation rate, slope of dose-effect relationship

Pharmacokinetics (PK)

Naloxone

“`
$\frac{d{T}_{1}}{dt}={K}_{tr}DF{e}^{-{K}_{tr}t}-{K}_{tr}{T}_{1}$
“`

“`
$\frac{d{T}_{2}}{dt}={K}_{tr}{T}_{1}-{K}_{in}{T}_{2}$
“`

“`
$\frac{dP}{dt}=\frac{{K}_{in}}{V}{T}_{2}-\frac{{C}_{L}}{V}P$
“`

– Ktr: Transition rate constant
– Kin: Absorption rate constant
– V: Volume of distribution
– CL: Total clearance
– T1, T2: Transition compartments
– P: Central compartment

Opioids

“`
$\frac{d{P}_{F}}{dt}={K}_{21}{P}_{F2}+{K}_{31}{P}_{F3}-{K}_{12}{P}_{F}-{K}_{13}{P}_{F}-{K}_{out}{P}_{F}$
“`

“`
$\frac{d{P}_{F2}}{dt}={-K}_{21}{P}_{F2}+{K}_{12}{P}_{F}$
“`

“`
$\frac{d{P}_{F3}}{dt}=-{K}_{31}{P}_{F3}+{K}_{13}{P}_{F}$
“`

– Kout: Elimination rate constant
– K12, K21: Forward and reverse rate constants between central and first peripheral compartment
– K13, K31: Forward and reverse rate constants between central and second peripheral compartment
– PF, PF2, PF3: Central and peripheral compartments

Pharmacodynamics (PD)

“`
$\frac{dL}{dt}=\frac{{k}_{1}{P}_{F}}{{V}_{c}{M}_{mass}}1e9-{k}_{1}L$
“`

“`
${V}_{F}=1- \alpha {R}_{L}$
“`

– k1: Biophase equilibriation term
– Vc: Central compartment volume
– Mmass: Molecular mass
– L: Effect site concentration
– VF: Fractional minute ventilation volume
– α: Opioid agonism coefficient
– RL: Fraction of opioid receptor occupancy

Mechanistic Model for Respiratory Depression Simulation under Opioid Agonists and Antagonists

Performance Comparison

The semi-mechanistic deep learning model outperformed the black-box model in accuracy. It simulated the mechanistic model behavior more closely. Both models were significantly faster than mechanistic model simulations.

Computational Efficiency

The mechanistic model required 30 minutes for one dosing scenario and over 10 days for all scenarios. In contrast, the neural networks processed one dosing scenario in 2-3 minutes and all scenarios in 19 minutes.

Conclusion

The updated mechanistic model serves as a flexible foundation for integrating system mechanisms into deep learning frameworks. The semi-mechanistic deep learning model strikes a balance between mechanistic interpretability and computational efficiency, surpassing the black-box model in accuracy. These advancements pave the way for AI-driven prediction and optimization of respiratory depression management during opioid administration.

By leveraging the mechanistic model’s insights, deep learning models can simulate complex physiological systems more accurately and efficiently. This integration enables personalized treatment strategies, improved patient outcomes, and enhanced understanding of drug effects. As AI continues to revolutionize healthcare, such collaborations between mechanistic modeling and deep learning hold immense promise for advancing medical research and clinical practice.